Suvaxyn PRRS MLV

Authorised

This medicine is authorised for use in the European Union

porcine respiratory and reproductive syndrome virus, live

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Suvaxyn PRRS MLV : EPAR - Medicine overview

Product information

Suvaxyn PRRS MLV : EPAR - Product Information

Suvaxyn PRRS MLV : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Suvaxyn PRRS MLV
• Active substance:
  Modified live porcine respiratory and reproductive syndrome virus
• International non-proprietary name (INN) or common name:
  porcine respiratory and reproductive syndrome virus, live

Authorisation details

• EMA product number:
  EMEA/V/C/004276

Assessment history

Changes since initial authorisation of medicine

Suvaxyn PRRS MLV : EPAR - Procedural steps taken and scientific information after authorisation

CVMP post-authorisation summary of positive opinion for Suvaxyn PRRS MLV (VRA-0011-G)

Adopted Reference Number: EMA/CVMP/265921/2024

CVMP post-authorisation summary of positive opinion for Suvaxyn PRRS MLV

Adopted Reference Number: EMA/CVMP/40684/2023

Suvaxyn PRRS MLV : EPAR - Scientific conclusions and grounds for amendment of the summary of product characteristics and package leaflet - Annex IV

Suvaxyn PRRS MLV-V-C-4276-II-0004/G : EPAR - Assessment report - Variation

Adopted

CVMP post-authorisation summary of positive opinion for Suvaxyn PRRS MLV

Adopted Reference Number: EMA/CVMP/199498/2019

Initial marketing authorisation documents

Suvaxyn PRRS MLV : EPAR - Public assessment report

Adopted

CVMP summary of positive opinion for Suvaxyn PRRS MLV

Adopted Reference Number: EMA/CVMP/327193/2017